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Recent advances in human pluripotent stem cell (hPSC) biology enable derivation of essentially any cell type in 
the human body, and development of three-dimensional (3D) tissue models for drug discovery, safety testing, 
disease modelling and regenerative medicine applications. However, limitations related to cell maturation, 
vascularization, cellular fidelity and inter-organ communication still remain. Relying on an engineering approach, 
microfluidics and microfabrication techniques our laboratory has developed new technologies aimed at 
overcoming them. 
 
Since native heart tissue is unable to regenerate after injury, induced pluripotent stem cells (iPSC) represent a 
promising source for human cardiomyocytes. Here, biological wire (Biowire) technology will be described, 
developed to specifically enhance maturation levels of hPSC based cardiac tissues, by controlling tissue 
geometry and electrical field stimulation regime (Nunes et al Nature Methods 2013). We will describe new 
applications of the Biowire technology in engineering a specifically atrial and specifically ventricular cardiac 
tissues, safety testing of small molecule kinase inhibitors, potential new cancer drugs, and modelling of left 
ventricular hypertrophy using patient derived cells.  
 
For probing of more complex physiological questions, dependent on the flow of culture media or blood, 
incorporation of vasculature is required, most commonly performed in organ-on-a-chip devices. Current organ-
on-a-chip devices are limited by the presence of non-physiological materials such as glass and drug-absorbing 
PDMS as well as the necessity for specialized equipment such as vacuum lines and fluid pumps that inherently 
limit their throughput. An overview of two new technologies, AngioChip (Zhang et al Nature Materials 2016) and 
inVADE (Lai et al Advanced Functional Materials 2017) will be presented, that overcome the noted limitations 
and enable engineering of vascularized liver, vascularized heart tissues and studies of cancer metastasis. 
These platforms enable facile operation and imaging in a set-up resembling a 96-well plate. Using polymer 
engineering, we were able to marry two seemingly opposing criteria in these platforms, permeability and 
mechanical stability, to engineer vasculature suitable for biological discovery and direct surgical anastomosis to 
the host vasculature.  
 
Finally, to enable minimally invasive delivery of engineered tissues into the body, a new shape-memory scaffold 
was developed that enables delivery of fully functional tissues on the heart, liver and aorta through a keyhole 





Figure 1 . Shape memory scaffold for minimally invasive delivery of functional tissues 
